Clinical Trial Update: S1505: Combination Chemotherapy or Gemcitabine Hydrochloride and Paclitaxel Albumin-Stabilized Nanoparticle Formulation Before Surgery in Treating Patients With Pancreatic Cancer That Can Be Removed by Surgery [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update evaluating combination chemotherapy or gemcitabine hydrochloride and paclitaxel albumin-stabilized nanoparticle formulation in res…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pancreatic Adenocarcinoma
• Resectable Pancreatic Carcinoma

Drugs mentioned

• Combination chemotherapy
• Gemcitabine hydrochloride and paclitaxel albumin-stabilized nanoparticle formulation

Snippet

Sponsor: SWOG Cancer Research Network | Conditions: Pancreatic Adenocarcinoma, Resectable Pancreatic Carcinoma | Phase 2 | Status: COMPLETED | Results posted: 2021-07-23